BRPI0415529A - derivados de bengamida, processos para produção dos mesmos e uso dos mesmos para tratamento de doenças cancerosas - Google Patents

derivados de bengamida, processos para produção dos mesmos e uso dos mesmos para tratamento de doenças cancerosas

Info

Publication number
BRPI0415529A
BRPI0415529A BRPI0415529-7A BRPI0415529A BRPI0415529A BR PI0415529 A BRPI0415529 A BR PI0415529A BR PI0415529 A BRPI0415529 A BR PI0415529A BR PI0415529 A BRPI0415529 A BR PI0415529A
Authority
BR
Brazil
Prior art keywords
production
processes
bengamide derivatives
cancerous diseases
treating cancerous
Prior art date
Application number
BRPI0415529-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Holger Hoffmann
Sabine Haag-Richter
Michael Kurz
Heiko Tietgen
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of BRPI0415529A publication Critical patent/BRPI0415529A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BRPI0415529-7A 2003-10-24 2004-10-08 derivados de bengamida, processos para produção dos mesmos e uso dos mesmos para tratamento de doenças cancerosas BRPI0415529A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10349669A DE10349669B3 (de) 2003-10-24 2003-10-24 Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
PCT/EP2004/011244 WO2005044803A1 (de) 2003-10-24 2004-10-08 Bengamide-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krebserkrankungen

Publications (1)

Publication Number Publication Date
BRPI0415529A true BRPI0415529A (pt) 2006-12-26

Family

ID=34484998

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415529-7A BRPI0415529A (pt) 2003-10-24 2004-10-08 derivados de bengamida, processos para produção dos mesmos e uso dos mesmos para tratamento de doenças cancerosas

Country Status (30)

Country Link
EP (2) EP1680405B1 (zh)
JP (1) JP4769190B2 (zh)
KR (1) KR20060120044A (zh)
CN (2) CN100398520C (zh)
AR (1) AR046553A1 (zh)
AT (2) ATE420074T1 (zh)
AU (1) AU2004287561B2 (zh)
BR (1) BRPI0415529A (zh)
CA (1) CA2543003A1 (zh)
CL (1) CL2009000674A1 (zh)
CY (1) CY1110458T1 (zh)
DE (3) DE10349669B3 (zh)
DK (1) DK1680405T3 (zh)
ES (1) ES2320894T3 (zh)
HK (1) HK1098131A1 (zh)
HR (1) HRP20090187T1 (zh)
IL (1) IL174524A (zh)
MA (1) MA28213A1 (zh)
ME (1) MEP33108A (zh)
MX (1) MXPA06004084A (zh)
NO (1) NO20062149L (zh)
NZ (1) NZ546744A (zh)
PL (1) PL1680405T3 (zh)
PT (1) PT1680405E (zh)
RS (1) RS20060263A (zh)
RU (1) RU2357956C2 (zh)
SI (1) SI1680405T1 (zh)
UY (1) UY28574A1 (zh)
WO (1) WO2005044803A1 (zh)
ZA (1) ZA200602231B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2878525B1 (fr) * 2004-11-29 2007-02-23 Aventis Pharma Sa Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
FR2878528B1 (fr) 2004-11-29 2008-05-16 Aventis Pharma Sa 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2901554B1 (fr) 2006-05-24 2011-04-01 Sanofi Aventis 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation
FR2901555A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation
FR2901556A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5140099A1 (es) * 1998-11-17 2002-03-22 Novartis Ag Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores
CA2405892C (en) * 2000-05-11 2009-07-07 Frederick Ray Kinder Jr. Substituted caprolactam carbonates and ethers and their use as anti-tumor agents
JP2004262793A (ja) * 2003-02-28 2004-09-24 Noyaku Bio Technology Kaihatsu Gijutsu Kenkyu Kumiai 化合物ｎ−９０１１、その製造法及び用途
AU2004263287B2 (en) * 2003-07-25 2009-02-12 Novartis Ag Substituted lactams and their use as anti-cancer agents

Also Published As

Publication number Publication date
EP1680405A1 (de) 2006-07-19
DE10349669B3 (de) 2005-05-25
CY1110458T1 (el) 2015-04-29
MEP33108A (en) 2010-10-10
IL174524A0 (en) 2006-08-01
ES2320894T3 (es) 2009-05-29
EP1873146B1 (de) 2010-08-11
AR046553A1 (es) 2005-12-14
HRP20090187T1 (en) 2009-05-31
MA28213A1 (fr) 2006-10-02
HK1098131A1 (en) 2007-07-13
ATE420074T1 (de) 2009-01-15
SI1680405T1 (sl) 2009-06-30
MXPA06004084A (es) 2006-06-27
PL1680405T3 (pl) 2009-06-30
DE502004011536D1 (de) 2010-09-23
JP4769190B2 (ja) 2011-09-07
AU2004287561B2 (en) 2011-06-02
WO2005044803A1 (de) 2005-05-19
ATE477244T1 (de) 2010-08-15
IL174524A (en) 2012-08-30
NZ546744A (en) 2009-03-31
ZA200602231B (en) 2007-06-27
DK1680405T3 (da) 2009-05-04
EP1680405B1 (de) 2009-01-07
EP1873146A3 (de) 2008-05-21
NO20062149L (no) 2006-07-11
EP1873146A2 (de) 2008-01-02
CN100398520C (zh) 2008-07-02
CN1871217A (zh) 2006-11-29
CL2009000674A1 (es) 2009-08-07
CN101294173A (zh) 2008-10-29
JP2007509084A (ja) 2007-04-12
RU2357956C2 (ru) 2009-06-10
PT1680405E (pt) 2009-03-31
RS20060263A (en) 2008-09-29
DE502004008837D1 (de) 2009-02-26
UY28574A1 (es) 2005-05-31
RU2006117769A (ru) 2007-11-27
CA2543003A1 (en) 2005-05-19
AU2004287561A1 (en) 2005-05-19
KR20060120044A (ko) 2006-11-24

Similar Documents

Publication Publication Date Title
MXPA03009840A (es) Derivados de fenilurea sustituidos con carboxamida y metodo para la produccion de los mismos como farmacos.
BRPI0307351B8 (pt) composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
MXPA04000622A (es) Pirazolilcarboxanilidas como funguicidas.
MXPA02011458A (es) Derivados de acilfenilurea, metodos para su produccion y uso de los mismos como farmacos.
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
AU2002314914A1 (en) Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
BR0310106A (pt) Composto, processo para a produção de um composto, composição farmacêutica, uso do composto e método para o tratamento de um sujeito em sofrimento de uma condição ou doença patalógica
BR0309355A (pt) 2-(2,6-diclorofenil)-diarilimidazóis
HK1050899A1 (en) Pteridine compounds for the treatment of psoriasis
HUP0100420A2 (hu) Új makrolidok és előállításuk
WO2002008194A8 (de) Acridin-derivate und deren verwendung als arzneimittel
MXPA03012013A (es) Derivados de 1-oxa-2,8-diaza-spiro[4,5]dec-2-eno sustituidos como medicamento para el tratamiento de dolor.
DE60112766D1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
SI1745010T1 (sl) Substituirani cikloheksil-1,4-diaminski derivati
TR200401669T1 (tr) Neoplastik hastalıkların tedavisi için metarix-metalloproteinazları önleyen kompozisyon.
WO2002010152A3 (de) Neue indolderivate und deren verwendung als arzneimittel
BR0312470A (pt) Composto, uso do mesmo, composição farmacêutica, método de tratar e/ou prevenir câncer, e, processo para preparar o composto
BRPI0415529A (pt) derivados de bengamida, processos para produção dos mesmos e uso dos mesmos para tratamento de doenças cancerosas
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 8A E 9A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2259 DE 22/04/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 8A, 9A, 10A, 11A, 12A, 13A, 14A, 15A E 16A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.